|
UBE2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.640000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.003100E-03 |
| Normal-vs-Stage2 |
8.235800E-01 |
| Normal-vs-Stage3 |
3.853400E-01 |
| Normal-vs-Stage4 |
5.631000E-01 |
| Stage1-vs-Stage2 |
1.572620E-01 |
| Stage1-vs-Stage3 |
1.376950E-04 |
| Stage1-vs-Stage4 |
2.208000E-01 |
| Stage2-vs-Stage3 |
8.159800E-01 |
| Stage2-vs-Stage4 |
6.002200E-01 |
| Stage3-vs-Stage4 |
3.002000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.284400E-02 |
| Normal-vs-AfricanAmerican |
5.402400E-01 |
| Normal-vs-Asian |
6.581600E-01 |
| Caucasian-vs-AfricanAmerican |
1.476770E-01 |
| Caucasian-vs-Asian |
1.444780E-01 |
| AfricanAmerican-vs-Asian |
5.963000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.233800E-04 |
| Normal-vs-Female |
2.170200E-01 |
| Male-vs-Female |
8.79390000041447E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.409800E-01 |
| Normal-vs-Extreme_Weight |
1.818550E-03 |
| Normal-vs-Obese |
5.271800E-01 |
| Normal-vs-Extreme_Obese |
2.321700E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.468360E-01 |
| Normal_Weight-vs-Obese |
4.431200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.720400E-01 |
| Extreme_Weight-vs-Obese |
3.769900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.567800E-01 |
| Obese-vs-Extreme_Obese |
2.261400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.595600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.425200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.158000E-03 |
| Normal-vs-Age(81-100Yrs) |
2.448100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.090100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.423300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.803840E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.807900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.534560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.034600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.241000E-03 |
| Normal-VS-Type2 PRCC |
2.379800E-01 |
| Normal-VS-KIRP CIMP |
1.496340E-03 |
| Normal-VS-Unclassified PRCC |
4.192200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.806400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.46249999996873E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
9.336100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.605800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.759400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.203200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.435600E-02 |
| Normal-vs-N1 |
2.746600E-01 |
| Normal-vs-N2 |
8.551000E-01 |
| N0-vs-N1 |
5.303200E-03 |
| N0-vs-N2 |
3.149400E-01 |
| N1-vs-N2 |
7.368600E-01 |
|
|
